Kenney Richard T 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed May 20, 2021
Insider Transaction Report
Form 4
Kenney Richard T
Chief Medical Officer
Transactions
- Purchase
Common Stock
2021-05-19$1.55/sh+10,000$15,500→ 35,000 total
Footnotes (1)
- [F1]Includes unvested RSUs.